Bristol Myers Squibb

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan
C-Suite

Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent cliff’ plan

By
December 5, 2025
Bristol-Myers Squibb (BMY) Q3 2025 Earnings Call Transcript

Contributing Writer

By
October 30, 2025
Bristol-Myers Squibb (BMY) Q2 2025 Earnings Call Transcript

Contributing Writer

By
July 31, 2025
Bristol-Myers Squibb (BMY) Q1 2025 Earnings Call Transcript

Contributing Writer

By
April 24, 2025
Cancer vaccination, conceptual illustration
Health

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

By
February 7, 2025
Bristol-Myers Squibb (BMY) Q4 2024 Earnings Call Transcript

Contributing Writer

By
February 6, 2025
A researcher examining a slide while standing with coworker in background at laboratory
Health

20 innovative breakthroughs that will transform your health

By
December 18, 2024
Developing new medicines for everyone, everywhere, equally
Commentary

Developing new medicines for everyone, everywhere, equally

By
November 13, 2023
Board members in discussion at conference table in office
Newsletters

Here’s what differentiates the top 25 corporate boards from their counterparts

By
May 12, 2023
François Locoh-Donou, CEO of F5 sits on a chair in his living room
Leadership

These 25 companies have the most ‘modern’ boards. Here’s what that means

By
May 10, 2023
Bristol-Myers Squibb logo on a smartphone
Newsletters

What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.

By Jeremy Kahn and Jonathan Vanian
January 25, 2022
Leaders from Peloton, Chobani, and more on how brands earn their purpose
Conferences

Leaders from Peloton, Chobani, and more on how brands earn their purpose

By
October 13, 2021
Moderna vaccine
Health

Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings

By
August 5, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech

British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company

By
June 15, 2021
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
Health

Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets

By Harris Meyer and Kaiser Health News
December 28, 2020

Most Popular